In accordance with these studies, we observed significantly increased level of Lp-PLA2 in the psoriatic patients compared to the controls (p < 0.001; Table 2), in the patients with MS compared to the controls with the MS (p < 0.001; Table 3), and in the patients without MS compared to the controls without MS (p < 0.001; Table 4). This evidence concerns the gene PLA2G7 and myeloid sarcoma.